Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracellular signaling in platelets.

Charles S Abrams1

  • 1University of Pennsylvania, Room 912, Biomedical Research Building II/III, 421 Curie Blvd., Philadelphia, PA 19104, USA. abrams@mail.med.upenn.edu

Current Opinion in Hematology
|August 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PITPβ Drives JAK2 V617F-Mediated Myeloproliferative Neoplasms by Promoting PtdIns(3,4)P <sub>₂</sub> -Dependent AKT Hyperactivation.

bioRxiv : the preprint server for biology·2026
Same author

Novel use of a hash-based tokenization for sharing sickle cell disease data without sharing protected health information.

Blood advances·2026
Same author

Graft-derived VWF drives platelet activation and thrombocytopenia during porcine liver xenotransplantation to brain-dead human recipients.

The Journal of clinical investigation·2026
Same author

Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedents.

Nature medicine·2026
Same author

The ASH Research Collaborative Sickle Cell Disease Research Network: past, present, and future.

Blood advances·2025
Same author

β-actin function in platelets and red blood cells can be performed by γ-actin and is therefore independent of actin isoform protein sequence.

Molecular biology of the cell·2024
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Platelet signaling pathways involving phosphatidylinositol 3-kinase and Rap1b are crucial for cell adhesion and aggregation. Understanding these pathways aids in developing targeted cardiovascular disease treatments.

Area of Science:

  • Molecular Biology
  • Hematology
  • Cell Signaling

Background:

  • Platelet research has increasingly focused on intracellular signaling pathways.
  • These pathways are critical for regulating platelet adhesion and aggregation.

Purpose of the Study:

  • To review recent findings on intracellular signaling events in platelets.
  • To highlight the role of novel signaling molecules in platelet function.
  • To discuss the clinical implications for diagnosis and drug design.

Main Methods:

  • Analysis of studies involving knockout mice to identify key signaling molecules.
  • Investigation of cytoskeletal protein interactions, specifically talin and integrin alphaIIbbeta3.
  • Review of existing literature on platelet signaling pathways and drug targets.

Related Experiment Videos

Main Results:

  • Identification of phosphatidylinositol 3-kinase, CalDAG-GEFI, and Rap1b as critical signaling molecules.
  • Evidence suggests these proteins remodel the platelet cytoskeleton, regulating adhesion and aggregation.
  • Talin acts as a key regulator of integrin alphaIIbbeta3, influencing fibrinogen binding avidity.

Conclusions:

  • Platelet signaling pathway identification has significant diagnostic and therapeutic implications.
  • Targeting specific pathways with novel agents offers potential for enhanced specificity and efficacy.
  • Existing drugs like aspirin and clopidogrel demonstrate the success of targeting platelet signaling in cardiovascular disease.